ATE455783T1 - Neue glucopyranoseester und glucofuranoseester von fumarsäurealkylestern und deren pharmazeutische verwendung - Google Patents
Neue glucopyranoseester und glucofuranoseester von fumarsäurealkylestern und deren pharmazeutische verwendungInfo
- Publication number
- ATE455783T1 ATE455783T1 AT06753340T AT06753340T ATE455783T1 AT E455783 T1 ATE455783 T1 AT E455783T1 AT 06753340 T AT06753340 T AT 06753340T AT 06753340 T AT06753340 T AT 06753340T AT E455783 T1 ATE455783 T1 AT E455783T1
- Authority
- AT
- Austria
- Prior art keywords
- esters
- glucofuranose
- glucopyranose
- new
- fumaric acid
- Prior art date
Links
- AVVWPBAENSWJCB-IVMDWMLBSA-N D-glucofuranose Chemical class OC[C@@H](O)[C@H]1OC(O)[C@H](O)[C@H]1O AVVWPBAENSWJCB-IVMDWMLBSA-N 0.000 title abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical class OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 title 2
- 239000001530 fumaric acid Substances 0.000 title 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 title 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200501002 | 2005-07-07 | ||
| PCT/DK2006/000403 WO2007006308A1 (en) | 2005-07-07 | 2006-07-07 | Novel glucopyranose esters and glucofuranose esters of alkyl- fu marates and their pharmaceutical use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE455783T1 true ATE455783T1 (de) | 2010-02-15 |
Family
ID=36840436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06753340T ATE455783T1 (de) | 2005-07-07 | 2006-07-07 | Neue glucopyranoseester und glucofuranoseester von fumarsäurealkylestern und deren pharmazeutische verwendung |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20100144651A1 (de) |
| EP (2) | EP1915387B1 (de) |
| AT (1) | ATE455783T1 (de) |
| DE (1) | DE602006011910D1 (de) |
| WO (1) | WO2007006308A1 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2526586C (en) | 2003-09-09 | 2010-03-16 | Biogen International Gmbh | The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| PL2316430T3 (pl) | 2004-10-08 | 2012-11-30 | Forward Pharma As | Kompozycje farmaceutyczne o kontrolowanym uwalnianiu, zawierające ester kwasu fumarowego |
| EP2680010A1 (de) | 2007-02-08 | 2014-01-01 | Biogen Idec MA Inc. | Nrf2-screening-assays sowie entsprechende verfahren und zusammensetzungen |
| RU2554347C2 (ru) * | 2008-08-19 | 2015-06-27 | Ксенопорт, Инк. | Пролекарства метилгидрофумарата, фармацевтические композиции с ними и способы применения |
| CN102369001A (zh) | 2009-01-09 | 2012-03-07 | 前进制药公司 | 包含溶蚀骨架中的一种或多种富马酸酯的药物制剂 |
| JP2012525385A (ja) | 2009-04-29 | 2012-10-22 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | 神経変性および神経炎症の治療 |
| US20130158077A1 (en) | 2011-12-19 | 2013-06-20 | Ares Trading S.A. | Pharmaceutical compositions |
| US20130259856A1 (en) * | 2012-03-27 | 2013-10-03 | Teva Pharmaceutical Industries, Ltd. | Treatment of multiple sclerosis with combination of laquinimod and dimethyl fumarate |
| CA2882730C (en) | 2012-08-22 | 2019-12-31 | Arbor Pharmaceuticals, Llc | Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof |
| US10945984B2 (en) | 2012-08-22 | 2021-03-16 | Arbor Pharmaceuticals, Llc | Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects |
| EP2934503B1 (de) | 2012-12-21 | 2019-04-10 | Biogen MA Inc. | Deuteriumsubstituierte fumaratderivate |
| US8669281B1 (en) | 2013-03-14 | 2014-03-11 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| KR102085557B1 (ko) | 2013-03-14 | 2020-03-06 | 엘커메스 파마 아일랜드 리미티드 | 푸마레이트의 프로드럭 및 다양한 질환을 치료하는데 있어서의 이들의 용도 |
| US10179118B2 (en) | 2013-03-24 | 2019-01-15 | Arbor Pharmaceuticals, Llc | Pharmaceutical compositions of dimethyl fumarate |
| US9302977B2 (en) | 2013-06-07 | 2016-04-05 | Xenoport, Inc. | Method of making monomethyl fumarate |
| US9421182B2 (en) | 2013-06-21 | 2016-08-23 | Xenoport, Inc. | Cocrystals of dimethyl fumarate |
| US9416096B2 (en) | 2013-09-06 | 2016-08-16 | Xenoport, Inc. | Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use |
| US20160214948A1 (en) * | 2013-09-27 | 2016-07-28 | Ratiopharm Gmbh | Prodrugs of monomethyl fumarate (mmf) |
| JP6337135B2 (ja) | 2014-02-24 | 2018-06-06 | アルカーメス ファーマ アイルランド リミテッド | フマル酸エステルのスルホンアミドプロドラッグ及びスルフィンアミドプロドラッグ並びに種々の疾患の治療におけるその使用 |
| US9999672B2 (en) | 2014-03-24 | 2018-06-19 | Xenoport, Inc. | Pharmaceutical compositions of fumaric acid esters |
| DK3273951T3 (da) | 2015-03-27 | 2020-11-02 | Symbionyx Pharmaceuticals Inc | Sammensætninger og fremgangsmåder til behandling af psoriasis |
| CA3102404A1 (en) | 2018-06-05 | 2019-12-12 | Flagship Pioneering Innovations V, Inc. | Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease |
| BR112021010893A2 (pt) | 2018-12-06 | 2021-08-31 | Flagship Pioneering Innovations V, Inc | Conjugados de fumarato de monometila-carreador e métodos para seu uso |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2530372A1 (de) * | 1975-07-08 | 1977-01-13 | Walter Dr Schweckendiek | Pharmazeutische zubereitungen zur behandlung von psoriasis |
| JPH02501202A (ja) | 1987-08-24 | 1990-04-26 | レニングラドスキ テフノロギチェスキ インスティテュト ツェルリュロズノ‐ブマジノイ プロミシレンノスティ | 基板上にレリーフ像を形成するための方法 |
| US4959389A (en) * | 1987-10-19 | 1990-09-25 | Speiser Peter P | Pharmaceutical preparation for the treatment of psoriatic arthritis |
| US5424332A (en) * | 1987-10-19 | 1995-06-13 | Speiser; Peter P. | Pharmaceutical composition and process for the production thereof |
| US5484610A (en) | 1991-01-02 | 1996-01-16 | Macromed, Inc. | pH and temperature sensitive terpolymers for oral drug delivery |
| DE19814358C2 (de) * | 1998-03-31 | 2002-01-17 | Fumapharm Ag Muri | Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn |
| DE19839566C2 (de) | 1998-08-31 | 2002-01-17 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten in der Transplantationsmedizin |
| DE19848260C2 (de) * | 1998-10-20 | 2002-01-17 | Fumapharm Ag Muri | Fumarsäure-Mikrotabletten |
| DE19853487A1 (de) * | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Verwendung von Dialkylfumaraten |
| US6537584B1 (en) | 1999-11-12 | 2003-03-25 | Macromed, Inc. | Polymer blends that swell in an acidic environment and deswell in a basic environment |
| DE10000577A1 (de) * | 2000-01-10 | 2001-07-26 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten |
| US7157423B2 (en) | 2001-01-12 | 2007-01-02 | Fumapharm Ag | Fumaric acid amides |
| WO2003004001A1 (en) | 2001-07-06 | 2003-01-16 | Lifecycle Pharma A/S | Controlled agglomeration |
| DE10214031A1 (de) | 2002-03-27 | 2004-02-19 | Pharmatech Gmbh | Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation |
-
2006
- 2006-07-07 WO PCT/DK2006/000403 patent/WO2007006308A1/en not_active Ceased
- 2006-07-07 DE DE602006011910T patent/DE602006011910D1/de active Active
- 2006-07-07 AT AT06753340T patent/ATE455783T1/de not_active IP Right Cessation
- 2006-07-07 EP EP06753340A patent/EP1915387B1/de active Active
- 2006-07-07 US US11/993,369 patent/US20100144651A1/en not_active Abandoned
- 2006-07-07 EP EP10151082A patent/EP2186819A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1915387A1 (de) | 2008-04-30 |
| DE602006011910D1 (de) | 2010-03-11 |
| US20100144651A1 (en) | 2010-06-10 |
| EP2186819A1 (de) | 2010-05-19 |
| WO2007006308A1 (en) | 2007-01-18 |
| EP1915387B1 (de) | 2010-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE455783T1 (de) | Neue glucopyranoseester und glucofuranoseester von fumarsäurealkylestern und deren pharmazeutische verwendung | |
| ATE432072T1 (de) | Verwendung von adapalen zur behandlung dermatologischer erkrankungen | |
| WO2007006307A3 (en) | Novel salts of fumaric acid monoalkylesters and their pharmaceutical use | |
| DOP2009000134A (es) | Compuestos bicíclicos y su uso como anti-diabéticos | |
| CY1109985T1 (el) | Αναστολεις πρωτεασωματος και μεθοδοι χρησης αυτων | |
| WO2008005303A3 (en) | Thiazolopyrimidine modulators of trpv1 | |
| ATE490984T1 (de) | Methode zur produktion und evaluierung der zytotoxizität von kir2dl nk-rezeptor antikörpern | |
| BRPI0507680A (pt) | partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas | |
| EA200970113A1 (ru) | Бензофуро- и бензотиенопиримидиновые модуляторы гистаминового рецептора н | |
| GB2453068A (en) | Novel hepatocyte-like cells and hepatoblast-like cells derived from hbs cells | |
| TW200942549A (en) | Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1 | |
| NO20075368L (no) | Antiinflammatoriske modaliteter | |
| ATE325789T1 (de) | Aminocyclohexylether-verbindungen und deren verwendung | |
| DE602005010821D1 (de) | Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren | |
| ATE482957T1 (de) | Arylessigsäure- und esterderivate und deren verwendung als entzündungshemmende mittel | |
| DE602004009030D1 (de) | Phenyltetrazol-Verbindungen | |
| CL2008002480A1 (es) | Compuestos derivados de 3-(4-aminofenil)-metil-4-hidroxi-5-amino-tiopirano, inhibidores de beta-secretasa bace; procedimiento de preparacion; composicion farmaceutica; combinacion farmaceutica, y su uso en el tratamiento de trastornos neurologicos o vaaculares, tal como la enfermedad de alzheimer, sindrome de down y deterioro de la memoria. | |
| ATE512133T1 (de) | 1h-pyrrol-2-carbonsäureamide und imidazol-5- carbonsäureamide und deren verwendung als fak-, kdr- und tie2-kinase-modulatoren zur behandlung von krebs | |
| DE602006007995D1 (de) | Formulierungen von liponsäure und hyaluronsäurebeneichen | |
| NO20082848L (no) | Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre | |
| ATE369371T1 (de) | 1-azadibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung | |
| ATE530552T1 (de) | Pyrrolobenzimidazolone und deren verwendung als antiproliferative mittel | |
| DE60327237D1 (de) | Dc-sign blockern und deren verwendung zur vorbeugung oder behandlung von viraleninfektionen | |
| DE602006014530D1 (de) | Pharmazeutisch aktive diazepane | |
| BR112012000410B8 (pt) | uso de benzidamina ou dos sais de adição de ácido, e, composição farmacêutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |